Most people with hypermobile joints are never formally diagnosed and never need treatment. Their flexibility causes no pain and no dysfunction. But for a significant minority, particularly those with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorder (HSD), the same tissue laxity that allows unusual range of motion also produces chronic joint pain, recurrent dislocations, fatigue, and a pattern of injury that does not fit standard sporting or trauma explanations. For this group, joint hypermobility treatment requires a specialist who understands the specific clinical picture of connective tissue laxity.
For international patients, India offers this specialist depth at NABH-accredited orthopaedic, sports medicine, and rheumatology centres at substantially lower cost than Western alternatives.
Understanding the Spectrum: From Benign Hypermobility to hEDS
Joint hypermobility is assessed clinically using the Beighton score, which assigns one point for each of the following:
-
Passive dorsiflexion of the little finger beyond 90 degrees (one point each hand)
-
Passive apposition of the thumb to the flexor forearm (one point each hand)
-
Hyperextension of the elbow beyond 10 degrees (one point each arm)
-
Hyperextension of the knee beyond 10 degrees (one point each knee)
-
Forward flexion of the trunk with palms flat on the floor with knees straight (one point)
A score of five or more out of nine is the threshold for generalised joint hypermobility in adults.
The Classification That Guides Treatment
Three conditions sit along the hypermobility spectrum, and distinguishing between them guides treatment planning:
-
Asymptomatic generalised joint hypermobility (aGJH): High Beighton score but no pain, instability, or functional impairment. No treatment required.
-
Hypermobility spectrum disorder (HSD): Hypermobility with symptomatic musculoskeletal consequences including pain, instability, or repeated soft tissue injuries, but not meeting the full diagnostic criteria for hEDS.
-
Hypermobile Ehlers-Danlos syndrome (hEDS): The most clinically significant form, defined by hypermobility plus systemic connective tissue features including skin extensibility, atrophic scarring, and one or more additional system involvements (autonomic dysfunction, functional gastrointestinal disorder, family history). The prevalence of EDS is between 0.2 and 10 per 1,000 people, with hypermobile type accounting for 80 to 90 percent of EDS cases.
Symptoms That Signal the Need for Treatment
Patients with persistent or serious joint hypermobility symptoms should seek specialist assessment when:
-
Dislocations or subluxations occur regularly in one or more joints without significant trauma
-
Joint pain persists for more than three months despite rest and basic analgesia
-
Multiple soft tissue injuries (sprains, strains) occur within the same joints repeatedly
-
Activity is significantly limited by fear of dislocation or post-activity pain
-
Standard physiotherapy has not produced lasting improvement
-
Sleep is disrupted by joint pain
The most commonly affected joints in symptomatic hypermobility are the shoulder (the most commonly affected large joint, due to its reliance on soft tissue rather than bony stabilisers), knee, hip, ankle, and the small joints of the hand and wrist.
Joint Hypermobility Treatment: The Full Pathway
Treatment for joint hypermobility follows a staged approach, moving from conservative management through to surgical stabilisation only when conservative measures have been fully optimised and failed.
Stage 1: Hypermobility-Focused Physiotherapy
Physiotherapy to strengthen muscles and stabilise the joints is the main form of management of hypermobile EDS and hypermobility spectrum disorders. This is not generic strengthening. It is a specific programme designed for the hypermobility context:
Key principles of hypermobility physiotherapy:
-
Proprioceptive retraining: Exercises that rebuild the joint's ability to sense its own position, correcting the proprioceptive deficit that drives repeated injury
-
Muscle co-contraction around unstable joints: Building the active stability that ligaments cannot provide
-
Postural awareness: Correcting compensatory postures adopted to avoid pain
-
Load management: Introducing resistance progressively with low repetitions to avoid tissue irritation
-
Joint protection strategies for daily activities and sport
Common errors in treating hypermobility with physiotherapy include pushing joints to their end-range of motion (which provides no benefit and irritates tissue) and excessive rest (which reduces muscle support and worsens instability over time). A therapist experienced specifically in hypermobility produces meaningfully different outcomes than one applying generic joint rehabilitation protocols.
Stage 2: Orthotic Support and Bracing
Custom orthoses and braces are used to provide joint support during activities where instability is symptomatic. They are not a substitute for physiotherapy but an adjunct that allows exercise to proceed safely during the strengthening phase:
-
Ankle-foot orthoses for ankle and subtalar instability
-
Knee bracing for patellar instability and knee hyperextension
-
Wrist splints and ring splints for hand and finger hypermobility
-
Shoulder bracing for glenohumeral instability during athletic activity Orthotics in India are fabricated by certified prosthetists and orthotists at NABH-accredited centres at a fraction of Western costs.
Stage 3: Pain Management Optimisation
Chronic pain in hEDS and HSD involves both peripheral (joint and soft tissue) and central (pain sensitisation) components. Pain management for joint hypermobility requires:
-
Structured pacing to manage energy expenditure and avoid post-exertional flares
-
Neuropathic pain agents (pregabalin, duloxetine) where central sensitisation is contributing
-
Low-dose naltrexone as an emerging option for chronic diffuse pain in connective tissue disorders
-
Avoidance of opioids as a long-term strategy, which consistently performs poorly in chronic hypermobility pain
Stage 4: Regenerative Injections
For specific joints with persistent pain and documented structural laxity that has not responded to physiotherapy, regenerative injection therapy under ultrasound guidance provides targeted treatment:
-
Prolotherapy: Dextrose injections at ligamentous insertion points stimulate an inflammatory healing response that strengthens lax ligamentous attachment sites. Several series have reported benefit for multi-joint hypermobility pain.
-
PRP (Platelet-Rich Plasma): Concentrated autologous platelets injected under imaging guidance reduce synovial inflammation and promote ligament healing. Available across India's leading sports medicine and orthopaedic centres.
Both are administered under ultrasound guidance at India's sports medicine and orthopaedic centres, at costs significantly below Western pricing.
Stage 5: Surgical Stabilisation for Recurrent Dislocations
Surgery for joint hypermobility is not the primary treatment. It is reserved for patients who have completed a comprehensive conservative programme and continue to experience dislocations that significantly impair function. Physiotherapy to strengthen muscles and stabilise the joints is the main form of management of hEDS and HSD, and the surgical team must take the connective tissue diagnosis into account in every aspect of the procedure.
Joint-specific surgical options at India's leading orthopaedic centres:
| Joint | Procedure | Indication |
|---|---|---|
| Shoulder | Arthroscopic Bankart repair, latissimus dorsi transfer | Recurrent anterior or posterior dislocation |
| Knee | Medial patellofemoral ligament (MPFL) reconstruction | Recurrent patellar dislocation |
| Ankle | Brostrom-Gould ligament reconstruction | Recurrent lateral ankle instability |
| Wrist | Ligament reconstruction with tenodesis | Carpal instability with failed conservative care |
Specific surgical considerations in hEDS and HSD patients include:
-
Skin and tissue fragility requiring multilayer wound closure to reduce tension
-
Avoidance of intramuscular injections due to bruising risk
-
Careful positioning on the operating table to avoid perioperative subluxation
-
Post-operative physiotherapy must be hypermobility-specific, not a standard joint replacement or sports injury protocol
Surgery in hypermobile patients carries a higher risk of complications including wound breakdown, and may produce less durable results than in non-hypermobile patients because the underlying connective tissue laxity persists. Realistic outcome expectations must be discussed thoroughly before any surgical commitment.
Why International Patients Choose India for Joint Hypermobility Treatment
India's leading sports medicine and orthopaedic hospitals offer the full treatment spectrum for joint hypermobility at NABH-accredited facilities with internationally trained specialists.
Cost Comparison
| Treatment | India cost | UK / USA equivalent |
|---|---|---|
| Hypermobility physiotherapy (per session) | Rs. 500 to Rs. 1,500 (USD 6 to USD 18) | USD 80 to USD 200 |
| PRP injection (per joint) | Rs. 8,000 to Rs. 20,000 (USD 96 to USD 240) | USD 500 to USD 1,500 |
| Custom orthotics | Rs. 3,000 to Rs. 15,000 (USD 36 to USD 180) | USD 400 to USD 1,500 |
| Arthroscopic shoulder stabilisation | Rs. 1,20,000 to Rs. 2,50,000 (USD 1,450 to USD 3,000) | USD 10,000 to USD 25,000 |
| MPFL reconstruction (knee) | Rs. 1,00,000 to Rs. 2,00,000 (USD 1,200 to USD 2,400) | USD 8,000 to USD 20,000 |
For patients with hip hypermobility and labral involvement, read: Traveling to India for Femoroacetabular Impingement Treatment: A Complete Patient Guide
How Karetrip Supports International Patients with Joint Hypermobility
Karetrip reviews each patient's clinical history, existing investigation results, and prior physiotherapy records before recommending a specialist in India, ensuring the proposed team has experience managing hypermobility-specific presentations rather than applying standard joint injury protocols. From pre-travel record review and medical visa coordination, through accommodation near the treating hospital and discharge planning for ongoing physiotherapy at home, Karetrip manages the complete international patient journey for joint hypermobility treatment in India.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward expert joint hypermobility assessment and treatment at India's leading orthopaedic and sports medicine centres.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Joint hypermobility and related disorders require evaluation by a qualified specialist in orthopaedics, rheumatology, or sports medicine before any treatment decision is made.